Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $2.84 | Prev. Close $2.84 | Circuit Range N/A |
Day Range $2.84 - $2.84 | Year Range $2.47 - $30.30 | Volume 165 |
Average Traded $2.84 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $2.84 | $2.84 | +0.00% |
06-Jan-26 | $2.84 | $2.84 | +0.00% |
02-Jan-26 | $2.84 | $2.84 | -1.90% |
31-Dec-25 | $2.95 | $2.90 | -6.91% |
30-Dec-25 | $3.01 | $3.11 | -5.47% |
29-Dec-25 | $3.38 | $3.29 | -4.36% |
23-Dec-25 | $3.44 | $3.44 | +2.99% |